Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18146 | 564 | 25.5 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
18146 | 1 | DICLOFENAC EPOLAMINE//TOPICAL NSAIDS//DICLOFENAC N 2 HYDROXYETHYLPYRROLIDINE | 564 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DICLOFENAC EPOLAMINE | authKW | 346490 | 1% | 80% | 8 |
2 | TOPICAL NSAIDS | authKW | 324825 | 2% | 50% | 12 |
3 | DICLOFENAC N 2 HYDROXYETHYLPYRROLIDINE | authKW | 270698 | 1% | 100% | 5 |
4 | REACTIVE DIMENSION | authKW | 216558 | 1% | 100% | 4 |
5 | SIZE AND SHAPE DESCRIPTORS | authKW | 216558 | 1% | 100% | 4 |
6 | DICLOFENAC SALTS | authKW | 216554 | 1% | 67% | 6 |
7 | TOPICAL DICLOFENAC | authKW | 194898 | 1% | 60% | 6 |
8 | TOPICAL PATCH | authKW | 169182 | 1% | 63% | 5 |
9 | STUDI FIS MACROMOL | address | 162419 | 1% | 100% | 3 |
10 | TDT 064 | authKW | 162419 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3602 | 47% | 0% | 264 |
2 | Rheumatology | 2052 | 11% | 0% | 63 |
3 | Medicine, General & Internal | 761 | 18% | 0% | 102 |
4 | Chemistry, Medicinal | 743 | 11% | 0% | 64 |
5 | Sport Sciences | 210 | 5% | 0% | 28 |
6 | Medicine, Research & Experimental | 193 | 8% | 0% | 45 |
7 | Orthopedics | 148 | 5% | 0% | 28 |
8 | Chemistry, Multidisciplinary | 144 | 13% | 0% | 74 |
9 | Primary Health Care | 128 | 2% | 0% | 9 |
10 | Anesthesiology | 41 | 2% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STUDI FIS MACROMOL | 162419 | 1% | 100% | 3 |
2 | ANEX ANALYT SERV LTD | 54140 | 0% | 100% | 1 |
3 | ARIZONA EDUC | 54140 | 0% | 100% | 1 |
4 | BEACHAM AMBULATORY CARE CLINJOHNS HOPKINS BAYVIE | 54140 | 0% | 100% | 1 |
5 | BETREUUNGZENTRUM SPORTMED | 54140 | 0% | 100% | 1 |
6 | BOYLES ANAESTHESIA PAIN MED | 54140 | 0% | 100% | 1 |
7 | CHAIR PHYS REHABILITAT MED | 54140 | 0% | 100% | 1 |
8 | CLIN BIOSTA | 54140 | 0% | 100% | 1 |
9 | COCHRANE PAIN PALLIAT CARE GRP | 54140 | 0% | 100% | 1 |
10 | DENT PHARM 2086 | 54140 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACEUTICA ACTA HELVETIAE | 11194 | 2% | 2% | 12 |
2 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 7501 | 3% | 1% | 16 |
3 | AKTUELLE RHEUMATOLOGIE | 4549 | 2% | 1% | 10 |
4 | CURRENT MEDICAL RESEARCH AND OPINION | 3916 | 3% | 0% | 18 |
5 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2104 | 4% | 0% | 25 |
6 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 2073 | 2% | 0% | 9 |
7 | ACTA THERAPEUTICA | 1959 | 1% | 1% | 3 |
8 | CLINICAL TRIALS AND META-ANALYSIS | 1932 | 0% | 4% | 1 |
9 | ACTA PHARMACEUTICA TECHNOLOGICA-INTERNATIONAL JOURNAL OF DRUG FORUMLATION AND BIOPHARMACEUTICS | 1930 | 0% | 2% | 2 |
10 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1892 | 2% | 0% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DICLOFENAC EPOLAMINE | 346490 | 1% | 80% | 8 | Search DICLOFENAC+EPOLAMINE | Search DICLOFENAC+EPOLAMINE |
2 | TOPICAL NSAIDS | 324825 | 2% | 50% | 12 | Search TOPICAL+NSAIDS | Search TOPICAL+NSAIDS |
3 | DICLOFENAC N 2 HYDROXYETHYLPYRROLIDINE | 270698 | 1% | 100% | 5 | Search DICLOFENAC+N+2+HYDROXYETHYLPYRROLIDINE | Search DICLOFENAC+N+2+HYDROXYETHYLPYRROLIDINE |
4 | REACTIVE DIMENSION | 216558 | 1% | 100% | 4 | Search REACTIVE+DIMENSION | Search REACTIVE+DIMENSION |
5 | SIZE AND SHAPE DESCRIPTORS | 216558 | 1% | 100% | 4 | Search SIZE+AND+SHAPE+DESCRIPTORS | Search SIZE+AND+SHAPE+DESCRIPTORS |
6 | DICLOFENAC SALTS | 216554 | 1% | 67% | 6 | Search DICLOFENAC+SALTS | Search DICLOFENAC+SALTS |
7 | TOPICAL DICLOFENAC | 194898 | 1% | 60% | 6 | Search TOPICAL+DICLOFENAC | Search TOPICAL+DICLOFENAC |
8 | TOPICAL PATCH | 169182 | 1% | 63% | 5 | Search TOPICAL+PATCH | Search TOPICAL+PATCH |
9 | TDT 064 | 162419 | 1% | 100% | 3 | Search TDT+064 | Search TDT+064 |
10 | CAS 15687 27 1 | 144361 | 1% | 33% | 8 | Search CAS+15687+27+1 | Search CAS+15687+27+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BARKIN, RL , (2015) TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: THE IMPORTANCE OF DRUG, DELIVERY, AND THERAPEUTIC OUTCOME.AMERICAN JOURNAL OF THERAPEUTICS. VOL. 22. ISSUE 5. P. 388 -407 | 63 | 77% | 6 |
2 | DERRY, S , MOORE, RA , GASKELL, H , MCINTYRE, M , WIFFEN, PJ , (2015) TOPICAL NSAIDS FOR ACUTE MUSCULOSKELETAL PAIN IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 6. P. - | 50 | 76% | 5 |
3 | DERRY, S , CONAGHAN, P , MOORE, RA , WIFFEN, PJ , DA SILVA, JAP , (2016) TOPICAL NSAIDS FOR CHRONIC MUSCULOSKELETAL PAIN IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 55 | 72% | 0 |
4 | DERRY, S , MOORE, RA , RABBIE, R , (2012) TOPICAL NSAIDS FOR CHRONIC MUSCULOSKELETAL PAIN IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 46 | 78% | 17 |
5 | RAINSFORD, KD , KEAN, WF , EHRLICH, GE , (2008) REVIEW OF THE PHARMACEUTICAL PROPERTIES AND CLINICAL EFFECTS OF THE TOPICAL NSAID FORMULATION, DICLOFENAC EPOLAMINE.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 24. ISSUE 10. P. 2967 -2992 | 49 | 54% | 29 |
6 | BREWER, AR , MCCARBERG, B , ARGOFF, CE , (2010) UPDATE ON THE USE OF TOPICAL NSAIDS FOR THE TREATMENT OF SOFT TISSUE AND MUSCULOSKELETAL PAIN: A REVIEW OF RECENT DATA AND CURRENT TREATMENT OPTIONS.PHYSICIAN AND SPORTSMEDICINE. VOL. 38. ISSUE 2. P. 62-70 | 31 | 82% | 9 |
7 | TAYLOR, RS , FOTOPOULOS, G , MAIBACH, H , (2011) SAFETY PROFILE OF TOPICAL DICLOFENAC: A META-ANALYSIS OF BLINDED, RANDOMIZED, CONTROLLED TRIALS IN MUSCULOSKELETAL CONDITIONS.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 27. ISSUE 3. P. 605 -622 | 34 | 68% | 15 |
8 | MASSEY, T , DERRY, S , MOORE, RA , MCQUAY, HJ , (2010) TOPICAL NSAIDS FOR ACUTE PAIN IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 6. P. - | 31 | 74% | 24 |
9 | WADSWORTH, LT , KENT, JD , HOLT, RJ , (2016) EFFICACY AND SAFETY OF DICLOFENAC SODIUM 2% TOPICAL SOLUTION FOR OSTEOARTHRITIS OF THE KNEE: A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 4 WEEK STUDY.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 32. ISSUE 2. P. 241 -250 | 24 | 73% | 1 |
10 | MAKRIS, UE , KOHLER, MJ , FRAENKEL, L , (2010) ADVERSE EFFECTS OF TOPICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN OLDER ADULTS WITH OSTEOARTHRITIS: A SYSTEMATIC LITERATURE REVIEW.JOURNAL OF RHEUMATOLOGY. VOL. 37. ISSUE 6. P. 1236-1243 | 28 | 65% | 22 |
Classes with closest relation at Level 1 |